BriaCell Therapeutics (BCTX) Institutional Ownership $4.65 +0.18 (+4.03%) As of 12:18 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BriaCell Therapeutics (NASDAQ:BCTX)CurrentInstitutional OwnershipPercentage15.42%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$3.76MNumber ofInstitutional Sellers(last 12 months)0 Get BCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BriaCell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCTX Institutional Buying and Selling by Quarter Remove Ads BriaCell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Cantor Fitzgerald L. P.56,000$32K0.0%N/A1.900% 2/11/2025 Virtu Financial LLC48,663$27K0.0%N/A1.650% 1/30/2025 Vontobel Holding Ltd.110,000$62K0.0%+37.5%0.249% 10/16/2024 Vontobel Holding Ltd.80,000$99K0.0%N/A0.438% 4/29/2024 Onyx Bridge Wealth Group LLC50,000$143K0.0%+66.7%0.313% 4/27/2024 K.J. Harrison & Partners Inc87,044$249K0.0%+7.8%0.545% 2/14/2024 Wasatch Advisors LP267,410$1.56M0.0%-48.0%1.673% 2/12/2024 Redmond Asset Management LLC133,569$781K0.3%-3.1%0.836% 2/6/2024 National Bank of Canada FI7,500$40K0.0%+200.0%0.047% 2/2/2024 K.J. Harrison & Partners Inc80,715$476K0.1%+22.1%0.505% Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024 Onyx Bridge Wealth Group LLC30,000$176K0.0%N/A0.188% 11/13/2023 K2 Principal Fund L.P.24,969$156K0.0%N/A0.156% 10/31/2023 K.J. Harrison & Partners Inc66,090$411K0.1%+90.8%0.414% 10/25/2023 Concord Wealth Partners10,775$67K0.0%-29.5%0.067% 8/11/2023 Natixis90,250$579K0.0%N/A0.565% 8/8/2023 Wasatch Advisors LP612,088$3.93M0.0%-0.6%3.830% 8/8/2023 Concord Wealth Partners15,275$98K0.0%-14.1%0.096% 8/2/2023 Bank of Montreal Can34,629$217K0.0%N/A0.217% 7/21/2023 K.J. Harrison & Partners Inc34,640$217K0.0%-67.3%0.217% 4/25/2023 K.J. Harrison & Partners Inc105,933$785K0.2%-75.2%0.683% 2/7/2023Lynwood Capital Management Inc.1,530,000$6.69M8.0%+27.7%9.860% 1/25/2023 K.J. Harrison & Partners Inc427,583$2.52B0.5%-10.9%2.755% 11/8/2022 Apollon Wealth Management LLC17,900$101K0.0%+12.6%0.115% 11/7/2022 Virtu Financial LLC48,347$272K0.0%+362.5%0.312% 10/25/2022Lynwood Capital Management Inc.1,198,000$6.73M7.4%+94.8%7.720% 10/21/2022 K.J. Harrison & Partners Inc479,838$2.75M1.0%-70.1%3.092% 8/11/2022 Apollon Wealth Management LLC15,900$92K0.0%+14.4%0.102% 8/2/2022Lynwood Capital Management Inc.615,000$3.55M4.0%-18.0%3.963% 7/27/2022 K.J. Harrison & Partners Inc1,607,027$9.19M2.5%+18.9%10.355% 5/5/2022Lynwood Capital Management Inc.750,000$7.61M8.2%-4.5%4.908% 4/21/2022 K.J. Harrison & Partners Inc1,351,782$13.75M2.2%N/A8.847% 4/20/2022 Concord Wealth Partners16,775$170K0.0%+31.3%0.110% 2/9/2022 Insight Advisors LLC PA16,900$140K0.0%N/A0.106% 2/3/2022 Total Clarity Wealth Management Inc.15,818$131K0.1%+38.5%0.099% 1/21/2022 Concord Wealth Partners12,775$106K0.0%N/A0.080% 11/16/2021 Two Sigma Investments LP62,139$503K0.0%N/A0.404% 11/16/2021 Voloridge Investment Management LLC156,946$1.27M0.0%N/A1.021% 10/22/2021 Redmond Asset Management LLC136,593$1.11M0.3%+3.7%0.890% 10/21/2021 Total Clarity Wealth Management Inc.11,425$93K0.0%N/A0.074% 10/19/2021 Belvedere Trading LLC13,608$107K0.0%N/A0.089% This could put Trump on new $100 bill (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited.10/13/2021 FNY Investment Advisers LLC4,687$37K0.0%N/A0.031% 10/13/2021Gofen & Glossberg LLC IL10,000$81K0.0%N/A0.065% 8/25/2021 Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/17/2021 Armistice Capital LLC570,343$3.04M0.1%N/A3.735% 8/16/2021 Sabby Management LLC196,033$1.05M0.1%+22.4%1.284% 8/16/2021 Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/13/2021 Altium Capital Management LP800,295$4.27M1.0%N/A5.241% 8/13/2021 Murchinson Ltd.250,000$1.33M0.5%N/A1.637% 8/12/2021 MMCAP International Inc. SPC400,000$2.13M0.1%N/A2.620% 8/12/2021 Kepos Capital LP500,000$2.67M0.2%N/A3.274% 8/12/2021 Eqis Capital Management Inc.21,182$113K0.0%+29.6%0.139% 8/11/2021CVI Holdings LLC320,800$1.71M0.1%N/A2.101% 5/19/2021 Virtu Financial LLC15,121$58K0.0%N/A0.260% 5/14/2021 Eqis Capital Management Inc.16,339$63K0.0%N/A0.281% 5/6/2021 Redmond Asset Management LLC131,731$508K0.2%N/A2.266% (Data available from 1/1/2016 forward)Remove Ads BCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCTX shares? During the previous two years, 12 institutional investors and hedge funds held shares of BriaCell Therapeutics. The most heavily invested institutionals were Wasatch Advisors LP ($1.56M), Redmond Asset Management LLC ($781K), Natixis ($579K), K.J. Harrison & Partners Inc ($249K), Bank of Montreal Can ($217K), K2 Principal Fund L.P. ($156K), and Onyx Bridge Wealth Group LLC ($143K).Learn more on BCTX's institutional investors. What percentage of BriaCell Therapeutics stock is owned by institutional investors? 15.42% of BriaCell Therapeutics stock is owned by institutional investors. Learn more on BCTX's institutional investor holdings. Which institutional investors have been buying BriaCell Therapeutics stock? Of the 9 institutional investors that purchased BriaCell Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vontobel Holding Ltd. ($110K), Natixis ($90.25K), Cantor Fitzgerald L. P. ($56K), K.J. Harrison & Partners Inc ($52.40K), Onyx Bridge Wealth Group LLC ($50K), Virtu Financial LLC ($48.66K), and Bank of Montreal Can ($34.63K). How much institutional buying is happening at BriaCell Therapeutics? Institutional investors have bought a total of 471,915 shares in the last 24 months. This purchase volume represents approximately $25.43M in transactions. Which BriaCell Therapeutics major shareholders have been selling company stock? The following institutional investors have sold BriaCell Therapeutics stock in the last 24 months: K.J. Harrison & Partners Inc ($392.94K), Wasatch Advisors LP ($250.34K), Concord Wealth Partners ($7K), and Redmond Asset Management LLC ($4.27K). How much institutional selling is happening at BriaCell Therapeutics? Institutional investors have sold a total of 654,554 shares in the last 24 months. This volume of shares sold represents approximately $65.85M in transactions. Related Companies UNCY Major Shareholders CUE Major Shareholders MRSN Major Shareholders IOBT Major Shareholders ACHL Major Shareholders OPTN Major Shareholders VOR Major Shareholders KRON Major Shareholders STTK Major Shareholders CRVO Major Shareholders This page (NASDAQ:BCTX) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCTX Stock Free BCTX Stock Alerts